The first stop for professional medicines advice

Guidance

663 results

Applied filters

(ATMPs)-The Role of Pharmacy in the Successful Delivery of Advanced Therapy Medicinal Products Information for Chief Pharmacists

7 August 2017Advice for Chief Pharmacists on Governance arrangements to ensure that ATMPs are of suitable quality and safe to use.

Standard Protocol for Deriving and Assessment of Stability - Part 5 Sterile Products

1 June 2017This protocol applies to small molecule products of all presentations, manufactured from non-sterile starting materials and sterilised in their final container.

A Standard Protocol for Derivation and Assessment of Stability Part 4 – Parenteral Nutrition

1 June 2017To support NHS compounding units and purchasers to derive and assess stability data for pharmaceutical products (Specials and extemporaneously compounded).

The Responsibilities of Chief Pharmacists for Radiopharmaceuticals (Yellow Cover)

28 April 2017Chief Pharmacist responsibilities with respect to radiopharmaceuticals have come more to the fore recently as a result of changes to the Ionising Radiation (Medical Exposure)…

Standard Protocol for Deriving and Assessment of Stability - Part 2: Aseptic Preparations (Biopharmaceuticals)

6 March 2017Stability of the protein structure is an important feature in preserving the safety and efficacy of biopharmaceuticals.

A Standard Protocol for Deriving and Assessment of Stability - Part 1 Aseptic Preparation

23 January 2017This YCD applies to small molecule products of all presentations prepared by aseptic manipulation of sterile pharmaceutical products.

Risk Associated with the Outsourcing of the Aseptic Compounding of Parenteral Nutrition (Yellow Cover)

16 December 2016The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…

Guidance Handling of Monoclonal Antibody (mAb) and Products (Yellow Cover)

16 December 2016Variation in practice underlined the need for an evidence-based guideline for handling mAbs that was suited to all those providing care to NHS patients.

Guidance on Managing The Sourcing and Supply of Ready-to-Administer Chemotheraphy Doses for the NHS (Yellow Cover)

5 December 2016This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.

Induction Programme for Trust Homecare Leads

30 August 2016The enclosed document has been drawn up as an aid for homecare leads in trusts.  It is meant to be used over a period of…
admin